Factors involved in the absence of sedative effects by the second-generation antihistamines.
Timmerman
H
H
Leiden/Amsterdam Center for Drug Research, Dept. Farmacochemie, Vrije Universiteit, Amsterdam, The Netherlands.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000145:classification / Q000493:pharmacokinetics*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D011969:Receptors, Histamine H1 / Q000378:metabolism
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D011969:Receptors, Histamine H1